retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor drug The Road towards Triple Agonists:
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18



01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)



:max_bytes(150000):strip_icc()/Health-GettyImages-2200929852-cbe13f76512c4cd3b51252536927920f.jpg)



















